Compounds > xanthenes
Page last updated: 2024-08-18

xanthenes and l 152804

xanthenes has been researched along with l 152804 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (80.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukami, T; Fukuroda, T; Hidaka, M; Ihara, M; Ishihara, A; Ishii, Y; Ito, J; Iwaasa, H; Kanatani, A; MacNeil, DJ; Nakamura, K; Okabe, T; Okamoto, O; Van der Ploeg, LH1
Asakawa, A; Cheng, JT; Dobashi, R; Fujimiya, M; Inui, A; Kaga, T; Kasuga, M; Liu, IM; Morimoto, Y; Nishimura, N; Okita, M; Ueno, N1
Carvalho, AP; Carvalho, CM; Malva, JO; Silva, AP1
Stratford, TR; Wirtshafter, D1
Bolwig, TG; Ernfors, P; Husum, H; Kokaia, M; Nanobashvili, A; Sørensen, AT; Sørensen, G; Woldbye, DP1
Hodge, CW; Overstreet, DH; Schroeder, JP1
Egashira, S; Fukami, T; Fukuroda, T; Gomori, A; Guan, X; Hidaka, M; Ihara, M; Ishihara, A; Ishii, Y; Iwaasa, H; Jitsuoka, M; Kanatani, A; MacNeil, DJ; Mashiko, S; Matsushita, H; Mitobe, Y; Murai, N; Murai, T; Nishikibe, M; Ohe, T; Okamoto, O; Sato, N; Tanaka, T; Van der Ploeg, LH1
Asakawa, A; Fujimiya, M; Herzog, H; Inui, A; Kasuga, M; Meguid, MM; Miyazaki, J; Ninomiya, M; Ueno, N; Yuzuriha, H1
Bengtsen, CH; Christiansen, SH; Dencker, D; Fink-Jensen, A; Jensen, M; Loland, CJ; Petersen, JH; Sørensen, G; Weikop, P; Woldbye, DP; Wörtwein, G1
Hara, T; Ide, S; Kaneda, K; Koseki, K; Maruyama, C; Minami, M; Naka, T; Ohno, A; Tamano, R; Yoshioka, M1

Other Studies

10 other study(ies) available for xanthenes and l 152804

ArticleYear
L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Biochemical and biophysical research communications, 2000, May-27, Volume: 272, Issue:1

    Topics: Administration, Oral; Animals; Cattle; CHO Cells; COS Cells; Cricetinae; Cyclohexanes; Eating; Humans; Injections, Intraventricular; Male; Neuropeptide Y; Pancreatic Polypeptide; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Xanthenes

2000
Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding.
    Diabetes, 2001, Volume: 50, Issue:5

    Topics: Aging; Animals; Arginine; Brain; Cyclohexanes; Dietary Sucrose; Energy Intake; Homozygote; Humans; Mice; Mice, Knockout; Mice, Transgenic; Neuropeptide Y; Obesity; Phenotype; Promoter Regions, Genetic; Receptors, Neuropeptide Y; Reference Values; Thy-1 Antigens; Xanthenes

2001
Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Neuropharmacology, 2003, Volume: 44, Issue:2

    Topics: Animals; Arginine; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cyclohexanes; Drug Interactions; Glutamic Acid; Hippocampus; Ionomycin; Ionophores; Neurons; Neuropeptide Y; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptide Fragments; Potassium Chloride; Rats; Rats, Wistar; Receptor Cross-Talk; Receptors, Neuropeptide Y; Synaptosomes; Xanthenes

2003
NPY mediates the feeding elicited by muscimol injections into the nucleus accumbens shell.
    Neuroreport, 2004, Dec-03, Volume: 15, Issue:17

    Topics: Analysis of Variance; Animals; Behavior, Animal; Cyclohexanes; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Eating; GABA Agonists; Male; Muscimol; Neuropeptide Y; Nucleus Accumbens; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Xanthenes

2004
Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
    Neurobiology of disease, 2005, Volume: 20, Issue:3

    Topics: Animals; Cells, Cultured; Convulsants; Cyclohexanes; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Hippocampus; Kainic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neurons; Neuropeptide Y; Organ Culture Techniques; Receptors, Neuropeptide Y; Synaptic Transmission; Xanthenes

2005
The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats.
    Alcohol (Fayetteville, N.Y.), 2005, Volume: 36, Issue:3

    Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Conditioning, Operant; Cyclohexanes; Eating; Male; Rats; Receptors, Neuropeptide Y; Self Administration; Xanthenes

2005
A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, May-02, Volume: 103, Issue:18

    Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Cyclohexanes; Diet; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Obesity; Organ Size; Rats; Rats, Zucker; Receptors, Neuropeptide Y; Weight Gain; Xanthenes

2006
Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, Volume: 21, Issue:9

    Topics: Animals; Arginine; Brain; Brain Chemistry; Cyclohexanes; Eating; Female; Folic Acid; Genes, Lethal; Genes, Synthetic; Ghrelin; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mice, Transgenic; Neural Tube Defects; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide Hormones; Peptide YY; Pregnancy; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Teratogens; Vitamin A; Xanthenes

2007
Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice.
    Psychopharmacology, 2012, Volume: 222, Issue:4

    Topics: Animals; Animals, Outbred Strains; Cocaine; Cocaine-Related Disorders; Corpus Striatum; Cyclohexanes; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Female; Hyperkinesis; Male; Mice; Mice, Knockout; Nucleus Accumbens; Receptors, Neuropeptide Y; Reinforcement, Psychology; Self Administration; Xanthenes

2012
Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Apr-03, Volume: 33, Issue:14

    Topics: Action Potentials; Affective Symptoms; Analysis of Variance; Aniline Compounds; Animals; Arginine; Corticotropin-Releasing Hormone; Cyclohexanes; Disease Models, Animal; Excitatory Amino Acid Antagonists; Formaldehyde; GABA Antagonists; Hormone Antagonists; Hormones; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Microdialysis; Neurons; Neuropeptide Y; Pain; Pain Measurement; Peptide Fragments; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Xanthenes

2013